YIELD GROWTH Announces Completion of FDA Compliant Evaluation with Human Subjects to Establish an SPF Factor of 31 for Urban Juve's Sunscreen Formula January 28, 2019 - Baystreet.ca VANCOUVER British Columbia based The Yield Growth Corp. (CSE:BOSS) (C:BOSS) (OTC:BOSQF) (Frankfort: YG3) earlier today announced completion of the United States Food and Drug Administration (FDA) compliant tests on human subjects to evaluate the effectiveness of Urban Juve’s proprietary sunscreen formula by determining a Sun Protection Factor (SPF) on human skin of 31. According to the Skin Cancer Foundation, SPF 30 product blocks 97% of UVB rays. Both the American Academy of Dermatology and the Canadian Dermatology Association advise using a sunscreen with an SPF of at least 30. Urban Juve’s sunscreen formula also passed the FDA broad spectrum test. Sunscreen products that pass the FDA broad spectrum test are allowed to be labeled as "Broad Spectrum”, meaning they protect against both UVA and UVB rays. According to the FDA, skin cancer is the most common cancer in the United States. Current estimates are that one in five Americans are at risk of developing skin cancer in their lifetime. Exposure to natural and artificial ultraviolet (UV) light has a direct impact on a person’s risk of developing skin cancer — despite age or skin type. Yield Growth subsidiary Urban Juve’s sunscreen contains natural ingredients and is free of petrochemicals, phthalates, propylene glycol, sulfates and parabens. Yield Growth subsidiary UJ Topicals has the rights to infuse this sunscreen formula with Cannabidiol (CBD). According to Statista, the global sun care market value was approximately $15.83 billion U.S. dollars in 2015, and is forecasted to reach $24.91 billion by 2024. The SPF evaluation for the Urban Juve sunscreen formula was completed by a fully independent testing facility at a laboratory in New York City, New York, USA, in compliance with FDA rules and regulations. About The Yield Growth Corp. The Yield Growth Corp. is dedicated to the rapid and sustainable growth of cannabis and wellness assets. Its directors and officers have experience at multi-billion dollar international companies including M.A.C Cosmetics, Aritzia, Skechers, Best Buy, Future Shop, Pepsi and Coca-Cola. Its key assets are 100% owned subsidiaries Urban Juve Provisions Inc., UJ Topicals Inc., UJ Beverages Inc. and Thrive Activations Inc. Through its subsidiaries it owns formulas to over 60 wellness products, including wellness formulas and beverages, has registered 29 products with Health Canada, has applied for 11 U.S. provisional patents and has established distribution and sales channels in Canada, the U.S. and Italy. It is currently selling products online and through retailers in Canada. For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop. Investor Relations Contacts: Penny Green, President & CEO Kristina Pillon, Investor Relations firstname.lastname@example.org 1-833-514-BOSS 1-833-514-2677 1-833-515-BOSS 1-833-515-2677 The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release. Cautionary Statement Regarding Forward-Looking Statements This press release includes forward-looking information and statements (collectively, “forward-looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve and UJ Topicals products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. Legal Disclaimer / Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this article is not provided to any individual with a view toward their individual circumstances. Baystreet.ca has been paid a fee of four thousand five hundred dollars for The Yield Growth Corp. advertising by Winning Media. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this article as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.